共 50 条
- [23] Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (18): : 1795 - 1797
- [25] Role of Glucagon-Like Peptide-1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (11):
- [28] A Clinical Overview of Once-weekly Glucagon-like Peptide-1 Receptor Agonists JOURNAL OF FAMILY PRACTICE, 2018, 67 (06): : S1 - S2
- [29] NEPHROPROTECTIVE POTENTIAL OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS DIABETES MELLITUS, 2020, 23 (01): : 56 - 64